Black Diamond Therapeutics
Deborah Dwyer currently serves as the Executive Director of Development Business Operations and Systems at Black Diamond Therapeutics, a position held since February 2023. Prior to this role, Deborah worked at Nuvation Bio as the Senior Director of Clinical Business Operations and Director of Clinical Business Operations from December 2019 to February 2023. Deborah also accumulated substantial experience at Nektar Therapeutics as Director and Associate Director of Clinical Outsourcing between January 2015 and December 2019, and at Cerexa as Associate Director of Clinical Outsourcing from June 2007 to December 2014. Additional experience includes serving as a Senior Clinical Research Associate Consultant and in various clinical program management roles at Chiron/Novartis and Genentech, Inc. Deborah holds a Bachelor of Arts in Environmental Science from the University of California, Berkeley, and an MBA from John F. Kennedy University.
This person is not in any teams
This person is not in any offices
Black Diamond Therapeutics
3 followers
Black Diamond Therapeutics is a leading venture-backed biotechnology company focused on the discovery and development of precision medicines for cancer that are directed against a novel class of allosteric mutant oncogenes.